YORVIPATH® (Palopegteriparatide)

Palopegteriparatide · Ascendis Pharma A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YORVIPATH® (Palopegteriparatide), covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding

See pricing